Perceptive Advisors as of Sept. 30, 2012
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 77 positions in its portfolio as reported in the September 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Infinity Pharmaceuticals (INFIQ) | 14.2 | $63M | 2.7M | 23.51 | |
Repros Therapeutics | 9.9 | $44M | 2.9M | 15.23 | |
Neurocrine Biosciences (NBIX) | 6.7 | $29M | 3.7M | 7.98 | |
Sarepta Therapeutics (SRPT) | 6.7 | $29M | 1.9M | 15.53 | |
Aegerion Pharmaceuticals | 5.8 | $26M | 1.7M | 14.82 | |
Neptune Technologies Bioreso | 4.5 | $20M | 5.0M | 3.95 | |
Gilead Sciences (GILD) | 4.1 | $18M | 273k | 66.33 | |
Capital Senior Living Corporation | 4.0 | $18M | 1.2M | 14.47 | |
ViroPharma Incorporated | 4.0 | $17M | 576k | 30.19 | |
Mylan | 3.0 | $13M | 534k | 24.37 | |
Shire | 2.4 | $11M | 120k | 88.70 | |
Express Scripts Holding | 2.3 | $10M | 164k | 62.63 | |
athenahealth | 2.1 | $9.2M | 100k | 91.77 | |
Celgene Corporation | 1.8 | $7.7M | 101k | 76.40 | |
Onyx Pharmaceuticals | 1.4 | $5.9M | 70k | 84.50 | |
Synta Pharmaceuticals | 1.3 | $5.7M | 742k | 7.62 | |
Covidien | 1.2 | $5.4M | 92k | 59.42 | |
Medivation | 1.2 | $5.2M | 93k | 56.34 | |
Dyax Corp | 1.1 | $5.0M | 1.9M | 2.60 | |
EXACT Sciences Corporation (EXAS) | 1.1 | $5.0M | 455k | 11.00 | |
PROLOR Biotech | 1.1 | $4.7M | 970k | 4.85 | |
Merck & Co (MRK) | 1.0 | $4.5M | 101k | 45.09 | |
Novartis (NVS) | 1.0 | $4.3M | 71k | 61.26 | |
Amgen | 1.0 | $4.2M | 50k | 84.29 | |
Conceptus | 0.9 | $4.0M | 196k | 20.31 | |
Celsion Corporation | 0.9 | $3.8M | 700k | 5.44 | |
Orexigen Therapeutics | 0.8 | $3.6M | 636k | 5.71 | |
Brookdale Senior Living (BKD) | 0.8 | $3.4M | 146k | 23.22 | |
DepoMed | 0.7 | $3.3M | 550k | 5.91 | |
Protalix BioTherapeutics | 0.7 | $2.9M | 564k | 5.18 | |
Cutera (CUTR) | 0.7 | $2.9M | 393k | 7.46 | |
ISIS Pharmaceuticals | 0.6 | $2.8M | 200k | 14.07 | |
Keryx Biopharmaceuticals | 0.6 | $2.8M | 987k | 2.82 | |
Uroplasty | 0.6 | $2.7M | 720k | 3.81 | |
NPS Pharmaceuticals | 0.6 | $2.7M | 288k | 9.25 | |
Anthera Pharmaceuticals | 0.6 | $2.5M | 2.6M | 0.99 | |
Neostem (NBS) | 0.5 | $2.3M | 3.3M | 0.69 | |
Questcor Pharmaceuticals | 0.5 | $2.2M | 120k | 18.48 | |
United Therapeutics Corporation (UTHR) | 0.5 | $2.3M | 40k | 55.88 | |
Lexicon Pharmaceuticals | 0.5 | $2.1M | 900k | 2.32 | |
Athersys | 0.5 | $2.0M | 1.5M | 1.39 | |
Affymax (AFFY) | 0.4 | $1.9M | 91k | 21.06 | |
Transgenomic | 0.4 | $1.9M | 2.0M | 0.95 | |
Vivus | 0.4 | $1.8M | 100k | 17.81 | |
MAKO Surgical | 0.4 | $1.8M | 102k | 17.41 | |
Jazz Pharmaceuticals (JAZZ) | 0.4 | $1.7M | 30k | 56.99 | |
Cadence Pharmaceuticals | 0.3 | $1.5M | 385k | 3.92 | |
Pharmacyclics | 0.3 | $1.3M | 20k | 64.50 | |
Amarin Corporation | 0.3 | $1.3M | 100k | 12.60 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.2 | $1.1M | 20k | 55.90 | |
Thoratec Corporation | 0.2 | $1.0M | 30k | 34.60 | |
Sunrise Senior Living | 0.2 | $1.0M | 73k | 14.27 | |
Achillion Pharmaceuticals | 0.2 | $1.1M | 101k | 10.41 | |
Star Scientific | 0.2 | $917k | 265k | 3.46 | |
Vical Incorporated | 0.2 | $866k | 200k | 4.33 | |
Ironwood Pharmaceuticals (IRWD) | 0.2 | $771k | 60k | 12.78 | |
DARA BioSciences | 0.2 | $788k | 750k | 1.05 | |
Mgc Diagnostics | 0.2 | $744k | 123k | 6.05 | |
Oncothyreon | 0.2 | $710k | 138k | 5.13 | |
XOMA CORP Common equity shares | 0.2 | $707k | 192k | 3.69 | |
Greenway Medical Technology | 0.1 | $657k | 38k | 17.11 | |
ProShares Ultra S&P500 (SSO) | 0.1 | $612k | 10k | 61.20 | |
INSTRS INC Stemcells | 0.1 | $477k | 232k | 2.06 | |
Spectranetics Corporation | 0.1 | $296k | 20k | 14.73 | |
Trinity Biotech | 0.1 | $279k | 22k | 12.59 | |
Exelixis (EXEL) | 0.1 | $241k | 50k | 4.82 | |
Emeritus Corporation | 0.1 | $211k | 10k | 20.89 | |
D Horizon Pharma | 0.0 | $175k | 50k | 3.50 | |
Celldex Therapeutics | 0.0 | $146k | 23k | 6.32 | |
Senesco Technologies | 0.0 | $133k | 634k | 0.21 | |
Verastem | 0.0 | $111k | 12k | 9.39 | |
BioMimetic Therapeutics | 0.0 | $109k | 26k | 4.13 | |
Aastrom Biosciences | 0.0 | $109k | 67k | 1.64 | |
Watson Pharmaceuticals | 0.0 | $26k | 300.00 | 86.67 | |
Genvec | 0.0 | $22k | 14k | 1.58 | |
Amicus Therapeutics (FOLD) | 0.0 | $2.0k | 300.00 | 6.67 | |
Combimatrix Corporation *w exp 05/01/201 | 0.0 | $5.0k | 50k | 0.10 |